Clock Reset on Denisovan-Neanderthal Split

Nuclear DNA from 430,000-year-old specimens indicates that Neanderthals had already diverged from their ancient-human predecessors.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIPEDIA, JOSE-MANUEL BENITO ALVAREZThe collection of ancient-human remains at the Sima de los Huesos cave in Spain has led scientists to rewrite the timeline for human history—again. Using nuclear DNA extracted from the 430,000-year-old bones of two individuals, researchers determined that the bones belonged to Neanderthals, who must have split previously from the predecessor they share with Denisovans, another ancient-human group.

Earlier mitochondrial analyses of ancient DNA sourced from the site suggested the inhabitants were related to Denisovans, perhaps representing a common predecessor of Neanderthals and Denisovans.

In this latest study, published today (March 14) in Nature, Matthias Meyer of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, and colleagues examined nuclear DNA. The genetic material revealed that the bones were related to Neanderthals, and not Denisovans. However, Meyer and his colleagues wrote in their report, “mitochondrial DNA recovered from one of the specimens shares the previously described relationship to Denisovan mitochondrial DNAs, suggesting, among other possibilities, that the mitochondrial DNA gene pool of Neanderthals turned over later in their history.”

Chris Stringer, a palaeoanthropologist at the Natural History Museum in London, told Science ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies